Shuo Ma

Associate Professor, Medicine, Hematology Oncology Division

Emailshuo-ma@northwestern.edu

Source: Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphoma. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.

Certifications and Licenses

	Medical Oncology
	Hematology
	Internal Medicine

Training Experience

2005	Residency, Resurrection Hospitals
2008	Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

PhD, Northwestern University, Feinberg School of Medicine

… → 2000

MD, Beijing Medical University

… → 1994

Research interests

Biologic Therapies
Blood Cancer (leukemia and lymphomas)
Chronic Lymphocytic Leukemia
Hematology
Non-Hodgkin's Lymphoma
Oncology

Fingerprint

Dive into the research topics where Shuo Ma is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

15 Finished
19 Active

Prot #LOXO-BTK-18001: A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin's Lymphoma (NHL)
Ma, S.
Covance Inc., Loxo Oncology, Inc.
12/8/20 → 12/8/23
Project: Research project
Prot #ACE-LY-003: An Open-label, Phase 1b/2 Study of Acalabrutinib Alone or in Combination Therapy in Subjects with B-cell Non-Hodgkin Lymphoma
Ma, S.
Syneos Health, Inc., Acerta Pharma, LLC
8/21/19 → 8/21/22
Project: Research project
Prot #U2-VEN-109: Phase I/II Study of Venetoclax in Combination with Ublituximab and Umbralisib (TGR-1202) in Patients with Relapsed or Refractory CLL/SLL
Ma, S.
TG Therapeutics, Inc.
4/12/19 → 4/12/24
Project: Research project
Prot #BGB-3111-212: An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined with Obinutuzumab Compared with Obinutuzumab Monotherapy in Relapsed/Refractory Follicular Lymphoma
Ma, S.
PRA Health Sciences, BeiGene Ltd.
2/8/19 → 2/8/22
Project: Research project
Prot #BGB-3111-304: An International, Phase 3, Open-label, Randomized Study of BGB-3111 Compared with Bendamustine plus Rituximab in Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Ma, S.
PRA Health Sciences, BeiGene Ltd.
2/5/19 → 2/5/22
Project: Research project

2620 Citations
27 Article
7 Review article
2 Chapter
2 Comment/debate
More

Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies
Stasiłojć, G., Felberg, A., Urban, A., Kowalska, D., Ma, S., Blom, A. M., Lundin, J., Österborg, A. & Okrój, M., Jan 2020, In: Journal of Immunological Methods. 476, 112675.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology
Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Lim, M. S., Ma, S. & 10 others, Malek, S., Mato, A., Mosse, C., Shadman, M., Siddiqi, T., Stephens, D., Sundaram, S., Wagner, N., Dwyer, M. & Sundar, H., Feb 1 2020, In: Journal of the National Comprehensive Cancer Network : JNCCN. 18, 2, p. 185-217 33 p.
Research output: Contribution to journal › Article › peer-review
8 Scopus citations
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
Noy, A., de Vos, S., Coleman, M., Martin, P., Flowers, C. R., Thieblemont, C., Morschhauser, F., Collins, G. P., Ma, S., Peles, S., Smith, S. D., Barrientos, J. C., Chong, E., Wu, S., Cheung, L. W. K., Kwei, K., Hauns, B., Arango-Hisijara, I. & Chen, R., Nov 24 2020, In: Blood Advances. 4, 22, p. 5773-5784 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Mato, A. R., Roeker, L. E., Lamanna, N., Allan, J. N., Leslie, L., Pagel, J. M., Patel, K., Osterborg, A., Wojenski, D., Kamdar, M., Huntington, S. F., Davids, M. S., Brown, J. R., Antic, D., Jacobs, R., Ahn, I. E., Pu, J., Isaac, K. M., Barr, P. M., Ujjani, C. S. & 42 others, Geyer, M. B., Berman, E., Zelenetz, A. D., Malakhov, N., Furman, R. R., Koropsak, M., Bailey, N., Hanson, L., Perini, G. F., Ma, S., Ryan, C. E., Wiestner, A., Portell, C. A., Shadman, M., Chong, E. A., Brander, D. M., Sundaram, S., Seddon, A. N., Seymour, E., Patel, M., Martinez-Calle, N., Munir, T., Walewska, R., Broom, A., Walter, H., El-Sharkawi, D., Parry, H., Wilson, M. R., Patten, P. E. M., Hernández-Rivas, J. Á., Miras, F., Escalada, N. F., Ghione, P., Nabhan, C., Lebowitz, S., Bhavsar, E., López-Jiménez, J., Naya, D., Garcia-Marco, J. A., Skånland, S. S., Cordoba, R. & Eyre, T. A., Sep 3 2020, In: Blood. 136, 10, p. 1134-1143 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
13 Scopus citations
Pseudo-Richter transformation of chronic lymphocytic leukaemia/small lymphocytic lymphoma following ibrutinib interruption: a diagnostic pitfall
Barnea Slonim, L., Ma, S., Behdad, A. & Chen, Q., Oct 1 2020, In: British Journal of Haematology. 191, 1, p. e22-e25
Research output: Contribution to journal › Letter › peer-review

Open Access